down arrow

Venus Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
305.00
8.1 (2.73%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
276.06
262.87
282.97
332.37
314.81
161.54
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
276.06
262.87
282.97
332.37
314.81
161.54
Raw Material Cost
147.03
172.80
176.84
224.73
200.89
78.73
Purchase of Finished goods
17.41
7.77
1.85
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.91
-35.11
-4.99
-9.27
-4.00
6.20
Employee Cost
39.78
34.45
31.50
25.26
23.41
21.32
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
54.75
54.77
50.29
47.51
63.32
32.81
Other Expenses
0.00
0.00
0.00
0.01
-0.01
-0.01
Total Expenditure (Excl Depreciation)
259.88
234.68
255.49
288.24
283.61
139.05
Operating Profit (PBDIT) excl Other Income
16.18
28.19
27.48
44.13
31.20
22.49
Other Income
12.17
5.31
3.23
4.84
14.31
2.17
Operating Profit (PBDIT)
28.35
33.50
30.71
48.97
45.51
24.66
Interest
0.04
0.12
0.26
0.17
10.25
11.09
Exceptional Items
0.00
0.00
0.00
0.00
-1.58
0.00
Gross Profit (PBDT)
28.31
33.38
30.45
48.80
33.68
13.57
Depreciation
12.39
13.99
16.79
17.33
17.20
17.06
Profit Before Tax
15.92
19.39
13.66
31.48
16.49
-3.49
Tax
11.18
8.27
1.44
-3.37
1.49
0.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4.74
11.12
12.22
34.85
15.00
-3.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4.74
11.12
12.22
34.85
15.00
-3.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4.74
11.12
12.22
34.85
15.00
-3.66
Equity Capital
13.37
13.37
13.37
13.37
12.34
12.34
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
421.91
0.00
0.00
Earnings per share (EPS)
3.55
8.32
9.14
26.07
12.16
-2.97
Diluted Earnings per share
3.54
8.32
9.14
26.41
12.15
-2.96
Operating Profit Margin (Excl OI)
5.86%
10.72%
9.71%
13.28%
9.91%
13.92%
Gross Profit Margin
10.26%
12.7%
10.76%
14.68%
10.7%
8.4%
PAT Margin
1.72%
4.23%
4.32%
10.49%
4.76%
-2.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 5.02% vs -7.10% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is -57.37% vs -9.00% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is -42.60% vs 2.58% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is -66.67% vs -53.85% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has fallen from Sep 2023

Compare Half Yearly Results Of Venus Remedies With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
276.06
5,969.93
-5,693.87
-95.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
276.06
5,969.93
-5,693.87
-95.38%
Raw Material Cost
147.03
934.97
-787.94
-84.27%
Purchase of Finished goods
17.41
857.27
-839.86
-97.97%
(Increase) / Decrease In Stocks
0.91
-104.82
105.73
100.87%
Employee Cost
39.78
1,280.21
-1,240.43
-96.89%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
54.75
0.00
54.75
Other Expenses
0.00
1,470.50
-1,470.50
-100.00%
Total Expenditure (Excl Depreciation)
259.88
4,438.13
-4,178.25
-94.14%
Operating Profit (PBDIT) excl Other Income
16.18
1,531.80
-1,515.62
-98.94%
Other Income
12.17
210.03
-197.86
-94.21%
Operating Profit (PBDIT)
28.35
1,741.83
-1,713.48
-98.37%
Interest
0.04
18.01
-17.97
-99.78%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
28.31
1,723.82
-1,695.51
-98.36%
Depreciation
12.39
213.36
-200.97
-94.19%
Profit Before Tax
15.92
1,510.46
-1,494.54
-98.95%
Tax
11.18
314.99
-303.81
-96.45%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
4.74
1,195.47
-1,190.73
-99.60%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
4.74
1,195.47
-1,190.73
-99.60%
Share in Profit of Associates
0.00
6.48
-6.48
-100.00%
Minority Interest
0.00
-11.99
11.99
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4.74
1,189.96
-1,185.22
-99.60%
Equity Capital
13.37
40.06
-26.69
-66.63%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.55
29.70
-26.15
-88.05%
Diluted Earnings per share
3.54
29.65
-26.11
-88.06%
Operating Profit Margin (Excl OI)
5.86%
25.66%
0.00
-19.80%
Gross Profit Margin
10.26%
28.88%
0.00
-18.62%
PAT Margin
1.72%
20.13%
0.00
-18.41%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 276.06 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 5.02% vs -7.10% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 4.74 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -57.37% vs -9.00% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.18 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -42.60% vs 2.58% in Sep 2023

Half Yearly - Interest
Interest 0.04 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -66.67% vs -53.85% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.86%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has fallen from Sep 2023